Standout Papers

The prevalence of pituitary adenomas 1994 2026 2004 2015 899
  1. The prevalence of pituitary adenomas (2004)
    Shereen Ezzat, L. Sylvia et al. Cancer
  2. Pathogenetic mechanisms in thyroid follicular-cell neoplasia (2006)
    Tetsuo Kondo, Shereen Ezzat et al. Nature reviews. Cancer
  3. Thyroid incidentalomas. Prevalence by palpation and ultrasonography (1994)
    Shereen Ezzat Archives of Internal Medicine
  4. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms (2022)
    Guido Rindi, Özgür Mete et al. Endocrine Pathology

Immediate Impact

3 by Nobel laureates 19 from Science/Nature 94 standout
Sub-graph 1 of 20

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
104 intermediate papers

Works of Shereen Ezzat being referenced

Thyroid incidentalomas. Prevalence by palpation and ultrasonography
1994 Standout
Thyroid Incidentalomas
1994
and 34 more

Author Peers

Author Last Decade Papers Cites
Shereen Ezzat 10887 4298 4163 315 16.0k
John Wass 13978 6061 3292 330 20.2k
Philippe Chanson 11489 5154 2678 380 16.1k
Electron Kebebew 9443 7437 3691 372 18.4k
Robert F. Gagel 6952 3854 3519 216 14.3k
Kálmán Kovács 15220 5856 3340 588 20.0k
Bruce G. Robinson 4941 2940 3323 227 11.1k
Orlo H. Clark 9299 7022 2942 345 16.6k
Mauro Papotti 5448 3845 2390 369 16.5k
Stephen M. Shalet 7875 1603 2921 266 13.3k
Manisha H. Shah 5334 2358 4162 198 17.4k

All Works

Loading papers...

Rankless by CCL
2026